Skip to main content
OpenTrials
Completed

NCT Number: NCT01477879

Hsv 1 and 2 Gowey Protocol Versus Placebo

This study will compare efficacy of versabase gel with 20% sarracenia purpurea versus placebo applied every 3-4 hours to herpes lesions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Herpes DNA Virus Infections Herpes Simplex Herpesviridae Infections Infections Skin Diseases Skin Diseases, Infectious Skin Diseases, Viral Skin and Connective Tissue Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Naturopaths international

Flagstaff, Arizona, 86001, United States

About this study

Patients screened for hsv one or two. Patients with herpes given a 1/8 oz of gel. Researcher does not know which is active and which is placebo (placebo is actually just versabase gel). Patent applies gel to lesions every 3-4 hours. Returns to clinic on days 3, 5, and 14 for evaluation. Up to 50 patients may be enrolled.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hsv 1&2

Exclusion criteria

  • No active lesions

Treatment and study plan

Versabase gel with sarracenia purpurea 20% liquid extract

Other

Topical application of gel/plant mix to lesions

placebo (versabase gel only)

Other

versabase gel only

Primary outcomes

  1. Pain

    Time frame: 2 weeks

    Pain scale-- subjective

  2. Size

    Time frame: 2 weeks

    Measure lesion size over 2 weeks

Secondary outcomes

  1. Appearance

    Time frame: 2 weeks

    Photo taken of lesion w patient informed consent

Sponsors and collaborators

Lead sponsor

Naturopaths International

Other

Registry information

Official study title

Phase II Clinical Trial of Versabase/Sarracenia Purpurea Versus Placebo

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Nov 23, 2011
Registry last updated
Nov 23, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.